MedPath

Risk prediction of progression to multiple myeloma from MGUS or smoldering myeloma by multi-color flow cytometric analysis

Not Applicable
Recruiting
Conditions
MGUS, smoldering myeloma, and multiple myeloma
Registration Number
JPRN-UMIN000031063
Lead Sponsor
Fukuoka University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion criteria are not set up. However, patients who received anti-myeloma treatment are excluded.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath